{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:18:23Z","timestamp":1792513103915,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Dental Journal"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.identj.2025.03.002","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T16:10:09Z","timestamp":1743610209000},"page":"1705-1712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Analysis of Adverse Events Associated With Dental Local Anaesthetics Using Food and Drug Administration Adverse Event Reporting System Data"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4395-4547","authenticated-orcid":false,"given":"Ferit","family":"Bayram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Akici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asli Melda","family":"Apari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8511-6349","authenticated-orcid":false,"given":"Volkan","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.identj.2025.03.002_bib0001","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/idj.12540","article-title":"Adverse drug reactions in dentistry","volume":"70","author":"Ouanounou","year":"2020","journal-title":"Int Dent J"},{"key":"10.1016\/j.identj.2025.03.002_bib0002","first-page":"546","article-title":"An update on local anesthetics in dentistry","volume":"68","author":"Haas","year":"2002","journal-title":"J Can Dent Assoc"},{"key":"10.1016\/j.identj.2025.03.002_bib0003","first-page":"971","article-title":"Local anesthetics: Dentistry's most important drugs, clinical update 2006","volume":"34","author":"Malamed","year":"2006","journal-title":"J Calif Dent Assoc"},{"key":"10.1016\/j.identj.2025.03.002_bib0004","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0011-8532(02)00018-6","article-title":"Adverse drug reactions to local anesthesia","volume":"46","author":"Finder","year":"2002","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.identj.2025.03.002_bib0005","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.oooo.2012.04.024","article-title":"Adverse drug reactions to local anesthetics: a systematic review","volume":"115","author":"Liu","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.identj.2025.03.002_bib0006","doi-asserted-by":"crossref","first-page":"956","DOI":"10.14219\/jada.archive.2012.0303","article-title":"From good to better: toward a patient safety initiative in dentistry","volume":"143","author":"Ramoni","year":"2012","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.identj.2025.03.002_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.adaj.2015.01.003","article-title":"Lessons learned from dental patient safety case reports","volume":"146","author":"Obadan","year":"2015","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.identj.2025.03.002_bib0008","unstructured":"U.S. Food and Drug Administration. FDA\u2019s adverse event reporting system (FAERS). Silver Spring, MD: U.S. Food and Drug Administration; 2024. Available fromhttps:\/\/www.fda.gov\/drugs\/surveillance\/fdas-adverse-event-reporting-system-faers. Accessed March 30, 2025."},{"key":"10.1016\/j.identj.2025.03.002_bib0009","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/bcpt.12357","article-title":"Paraesthesia after local anaesthetics: an analysis of reports to the FDA adverse event reporting system","volume":"117","author":"Piccinni","year":"2015","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.identj.2025.03.002_bib0010","doi-asserted-by":"crossref","first-page":"W163","DOI":"10.7326\/0003-4819-147-8-200710160-00010-w1","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"147","author":"Vandenbroucke","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.identj.2025.03.002_bib0011","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40264-014-0150-2","article-title":"The Weber effect and the United States Food and Drug Administration's adverse event reporting system (FAERS): analysis of sixty-two drugs approved from 2006 to 2010","volume":"37","author":"Hoffman","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.identj.2025.03.002_bib0012","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s11523-021-00841-2","article-title":"Niraparib: a review in first-line maintenance therapy in advanced ovarian cancer","volume":"16","author":"Lee","year":"2021","journal-title":"Target Oncol"},{"key":"10.1016\/j.identj.2025.03.002_bib0013","first-page":"ZE07","article-title":"Death rate of dental anaesthesia","volume":"11","author":"Mortazavi","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.identj.2025.03.002_bib0014","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41405-024-00210-x","article-title":"Knowledge and attitudes toward anaphylaxis to local anesthetics in dental practice","volume":"10","author":"Cherrez-Ojeda","year":"2024","journal-title":"BDJ Open"},{"key":"10.1016\/j.identj.2025.03.002_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.adaj.2023.08.005","article-title":"Survey investigation of articaine use in the United States","volume":"154","author":"Bowers","year":"2023","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.identj.2025.03.002_bib0016","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/sj.bdj.4812097","article-title":"Drug information handbook for dentistry: oral medicine for medically-compromised patients and specific conditions","volume":"198","author":"Lamey","year":"2005","journal-title":"Br Dent J"},{"key":"10.1016\/j.identj.2025.03.002_bib0017","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41405-022-00113-9","article-title":"Articaine: dental practitioner use, basis of perception and evidence-based dentistry\u2014a cross-sectional study","volume":"8","author":"Martin","year":"2022","journal-title":"BDJ Open"},{"key":"10.1016\/j.identj.2025.03.002_bib0018","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.coms.2021.08.003","article-title":"Updates on topical and local anesthesia agents","volume":"34","author":"Mundiya","year":"2022","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.identj.2025.03.002_bib0019","doi-asserted-by":"crossref","first-page":"39","DOI":"10.17245\/jdapm.2022.22.1.39","article-title":"Does the presence and amount of epinephrine in 2% lidocaine affect its anesthetic efficacy in the management of symptomatic maxillary molars with irreversible pulpitis?","volume":"22","author":"Singla","year":"2022","journal-title":"J Dent Anesth Pain Med"},{"key":"10.1016\/j.identj.2025.03.002_bib0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.tripleo.2011.04.037","article-title":"Comparison of 4% articaine with epinephrine (1:100,000) and without epinephrine in inferior alveolar block for tooth extraction: double-blind randomized clinical trial of anesthetic efficacy","volume":"113","author":"Kammerer","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.identj.2025.03.002_bib0021","first-page":"6","article-title":"Exogenous and endogenous plasma levels of epinephrine during dental treatment under local anesthesia","volume":"18","author":"Lipp","year":"1993","journal-title":"Reg Anesth"},{"key":"10.1016\/j.identj.2025.03.002_bib0022","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2344\/0003-3006-59.2.90","article-title":"Local anesthetics: review of pharmacological considerations","volume":"59","author":"Becker","year":"2012","journal-title":"Anesth Prog"},{"key":"10.1016\/j.identj.2025.03.002_bib0023","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/00128071-200102060-00001","article-title":"Do women have more adverse drug reactions?","volume":"2","author":"Rademaker","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.identj.2025.03.002_bib0024","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ijom.2005.10.004","article-title":"Nerve injury caused by mandibular block analgesia","volume":"35","author":"Hillerup","year":"2006","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.identj.2025.03.002_bib0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.coms.2011.04.009","article-title":"Complications of local anesthesia used in oral and maxillofacial surgery","volume":"23","author":"Cummings","year":"2011","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.identj.2025.03.002_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdent.2022.104157","article-title":"Comparing oral health behaviours of men and women in the United States","volume":"122","author":"Su","year":"2022","journal-title":"J Dent"},{"key":"10.1016\/j.identj.2025.03.002_bib0027","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1902\/jop.2010.100444","article-title":"Sex differences in gingivitis relate to interaction of oral health behaviors in young people","volume":"82","author":"Furuta","year":"2011","journal-title":"J Periodontol"},{"key":"10.1016\/j.identj.2025.03.002_bib0028","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10389-007-0126-0","article-title":"Female gender is associated with dental care and dental hygiene, but not with complete dentition in the Swiss adult population","volume":"15","author":"Coda Bertea","year":"2007","journal-title":"J Public Health"},{"key":"10.1016\/j.identj.2025.03.002_bib0029","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jbi.2015.02.004","article-title":"Utilizing social media data for pharmacovigilance: a review","volume":"54","author":"Sarker","year":"2015","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.identj.2025.03.002_bib0030","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3390\/ph15060675","article-title":"Pharmacovigilance signals of the opioid epidemic over 10 years: data mining methods in the analysis of pharmacovigilance datasets collecting adverse drug reactions (ADRs) reported to EudraVigilance (EV) and the FDA adverse event reporting system (FAERS)","volume":"15","author":"Chiappini","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.identj.2025.03.002_bib0031","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1111\/bcp.15874","article-title":"Unintended impact of pharmacovigilance regulatory interventions: a systematic review","volume":"89","author":"Lasys","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.identj.2025.03.002_bib0032","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40801-018-0134-0","article-title":"Spontaneous reporting on adverse events by consumers in the United States: an analysis of the Food and Drug Administration adverse event reporting system database","volume":"5","author":"Toki","year":"2018","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.identj.2025.03.002_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinthera.2020.12.008","article-title":"Effects of the COVID-19 pandemic on spontaneous reporting: global and national time-series analyses","volume":"43","author":"Hauben","year":"2021","journal-title":"Clin Ther"},{"key":"10.1016\/j.identj.2025.03.002_bib0034","doi-asserted-by":"crossref","first-page":"402","DOI":"10.5005\/jp-journals-10015-1661","article-title":"Pharmacovigilance: the least understood and least practiced science in dentistry","volume":"10","author":"Sharma","year":"2019","journal-title":"World J Dent"},{"key":"10.1016\/j.identj.2025.03.002_bib0035","article-title":"Evaluation of health care professionals\u2019 knowledge, attitudes, practices and barriers to pharmacovigilance and adverse drug reaction reporting: a cross-sectional multicentral study","volume":"18","author":"Khan","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.identj.2025.03.002_bib0036","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00228-017-2309-0","article-title":"The key role of clinical and community health nurses in pharmacovigilance","volume":"73","author":"Bigi","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.identj.2025.03.002_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1320458","article-title":"A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database","volume":"14","author":"Zou","year":"2023","journal-title":"Front Pharmacol"}],"container-title":["International Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020653925000735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020653925000735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T09:30:54Z","timestamp":1746783054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0020653925000735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0020653925000735"],"URL":"https:\/\/doi.org\/10.1016\/j.identj.2025.03.002","relation":{},"ISSN":["0020-6539"],"issn-type":[{"value":"0020-6539","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of Adverse Events Associated With Dental Local Anaesthetics Using Food and Drug Administration Adverse Event Reporting System Data","name":"articletitle","label":"Article Title"},{"value":"International Dental Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.identj.2025.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of FDI World Dental Federation.","name":"copyright","label":"Copyright"}]}}